Inhibitory effect of umbilical cord blood mesenchymal stem cells versus bone marrow mesenchymal stem cells on lymphocyte proliferation
贺文凤,石庆之,华建媛,李剑,李洁,吴琼
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.24.004
2007-01-01
Abstract:AIM: To compare the inhibitory effect of umbilical cord blood mesenchymal stem cells (UCB-MSCs) and bone marrow mesenchymal stem cells (BM-MSCs) on lymphocytes (LCs) proliferation stimulated by phytohemagglutinin (PHA). METHODS: The experiment was conducted from July 2005 to March 2006 in Hematology Institute of Second Affiliated Hospital of Nanchang University and Jiangxi Medical Molecule Key Laboratory. ①Umbilical cord blood samples (n =9) were collected from healthy baby in Department of Gynecology and Obstetrics of Second Affiliated Hospital of Nanchang University. Puerperants and their family members signed the informed consent. Normal bone marrow (n =9) was harvested from inpatients and Out-Patient Clinic patients of Department of Hematology of Second Affiliated Hospital of Nanchang University. All the persons were with donation consent. Peripheral blood (n =9) was collected from normal volunteers. The trial was approved by medical ethics committee. ②Mononuclear cells (MNCs) were isolated from UCB, BM and peripherial blood, respectively. UCB-MNCs and BM-MNCs were cultured in the IMDM culture liquid containing calf serum of 0.1 volume fraction and 1×10-3 mol/L cetacort in culture flask at concentration of 1×109 L-1. The culture liquid was replaced after 7 days, and then replaced every 3 or 4 days after removing suspension cells. The cells were serial subcultivation by trypase-EDTA after the cells confusion reached 90% and the third generation cells were used in the experiment. Peripheral blood cells (PBCs) were cultured in the IMDM liquid containing calf serum of 0.1 volume fraction and 10 mg/L PHA in culture flask at concentration of 1×109 L-1, and the cells were harvested after 3-day culture. ③The MSCs and LCs surface molecules were identified by flow cytometry. The differentiation capacities of UCB-MSCs and BM-MSCs into the adipocytes were assessed with histochemical solution. UCB-MSCs and BM-MSCs with various concentrations were added to PHA-induced proliferation system, and then the inhibitory effects of UCB-MSCs and BM-MSCs on proliferation and regulation of LCs were compared. RESULTS: ①Culture and identification of UCB-MSCs and BM-MSCs: The expressions of surface molecules about CD29, CD166, CD54, CD45, CD13 and CD34 on MSCs were 85.18%, 72.52%, 33.70%, 6.70%, 1.51% and 0.23%, respectively. The surface molecules expression about CD3+ T and CD20+B of PBCs were 60%-70% and 3.5%-4.5%, respectively. UCB-MSCs became into adipocyte which color was yellow after cultured 3 weeks. ②Inhibitory effect of UCB-MSCs and BM-MSCs: When MSCs and LCs mixed at the ratio of 1∶1, 0.5∶1, 0.1∶1, 0.05∶1, 0.02∶1, 0.01∶1, the inhibitory rates of UCB-MSCs on LCs proliferation were (49.5±4.8)%,(58.4±6.0)%,(38.1±4.0)%,(31.4±3.2)%,(24.3±3.2)%,(12.6±6.7)%, respectively, whereas that of BM-MSCs were (52.4±8.4)%,(65.1±9.7)%,(34.7±4.5)%,(13.0±6.4)%,(-10.7±12.6)%, (-43.9±9.4)%, respectively. When the ratio was 0.05:1, 0.02:1 and 0.01:1, the inhibitory effect of UCB-MSCs was much better than that of the BM-MSCs (t =7.72,8.14,14.68,P < 0.05). CONCLUSION: Both UCB-MSCs and BM-MSCs showed inhibitory effect on PHA-induced LCs proliferation and the effect was associated with the number of MSCs. The inhibitory effect of UCB-MSCs was much stronger than that of BM-MSCs at low concentration.